- Business Wire•11 days agoEnzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay
Enzo Biochem, Inc. today announced that the New York State Department of Health has granted conditional approval for use of Enzo Clinical Labs’ PLAQPRO™ Lp-PLA2 Assay.
- Capital Cube•2 months ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Enzo Biochem, Inc.Here are 5 ETF’s with the largest exposure to ENZ-US. Comparing the performance and risk of Enzo Biochem, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Enzo Biochem, Inc. : July 19, 2016 appeared first on CapitalCube.
Enzo Biochem Inc. (ENZ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||5.08 x 1200|
|Ask||5.09 x 1600|
|Day's Range||4.88 - 5.18|
|52wk Range||3.38 - 7.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||13.32|
|Avg Vol (3m)||187,209|
|Dividend & Yield||N/A (N/A)|